Pin53 - Is the Recombinant Zoster Vaccine Also Cost-Effective for the German Population ≥50 Years of Age?
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1372
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV